Recursion Wins FDA Approval for Phase 1 Trials of AI-Found Cancer Drug
October 7, 2024 : Recursion Pharmaceuticals, a pioneering biotechnology company leveraging artificial intelligence (AI) for drug discovery, has secured approval from the U.S.
Study: Novo Nordisk’s Ozempic May Reduce Opioid Overdose Risk
September 26, 2024 : A recent study has suggested that Ozempic, a diabetes medication manufactured by Novo Nordisk, may lower the risk of opioid overdoses.
